In contrast to SPARC, GRP78, which is often upregulated on the cell surface in malignancy, can interact with PI3K, CRIPTO, IGF1-R in the breast, prostate, and hepatoma cells, respectively, to promote oncogenic events33–37. This evidence concerns the gene IGF1R and hepatocellular carcinoma.